Intratumoral heterogeneity and clonal evolution in liver cancer.
Bojan LosicAmanda J CraigCarlos Villacorta-MartinSebastiao N Martins-FilhoNicholas AkersXintong ChenMehmet Eren AhsenJohann von FeldenIsmail LabgaaDelia DʹAvolaKimaada AlletteSergio A LiraGlaucia C FurtadoTeresa Garcia-LezanaPaula RestrepoAshley StueckStephen C WardMaria I FielSpiros P HiotisGanesh GunasekaranDaniela SiaEric E SchadtRobert SebraMyron E SchwartzJosep M LlovetSwan ThungGustavo StolovitzkyAugusto VillanuevaPublished in: Nature communications (2020)
Clonal evolution of a tumor ecosystem depends on different selection pressures that are principally immune and treatment mediated. We integrate RNA-seq, DNA sequencing, TCR-seq and SNP array data across multiple regions of liver cancer specimens to map spatio-temporal interactions between cancer and immune cells. We investigate how these interactions reflect intra-tumor heterogeneity (ITH) by correlating regional neo-epitope and viral antigen burden with the regional adaptive immune response. Regional expression of passenger mutations dominantly recruits adaptive responses as opposed to hepatitis B virus and cancer-testis antigens. We detect different clonal expansion of the adaptive immune system in distant regions of the same tumor. An ITH-based gene signature improves single-biopsy patient survival predictions and an expression survey of 38,553 single cells across 7 regions of 2 patients further reveals heterogeneity in liver cancer. These data quantify transcriptomic ITH and how the different components of the HCC ecosystem interact during cancer evolution.
Keyphrases
- single cell
- rna seq
- hepatitis b virus
- papillary thyroid
- immune response
- high throughput
- squamous cell
- poor prognosis
- genome wide
- end stage renal disease
- climate change
- induced apoptosis
- ejection fraction
- squamous cell carcinoma
- lymph node
- sars cov
- big data
- peritoneal dialysis
- cell free
- young adults
- fine needle aspiration
- high density
- mass spectrometry
- binding protein
- dna methylation
- cell proliferation
- liver failure
- childhood cancer
- cell cycle arrest
- patient reported
- cross sectional
- genetic diversity
- replacement therapy
- monoclonal antibody
- circulating tumor cells